| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.2 | 0.0009 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.002 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.002 |